Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 433

1.

Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.

El Cheikh J, Kfoury E, Calmels B, Lemarie C, Stoppa AM, Bouabdallah R, Coso D, Schiano De Collela JM, Ladaique P, Gastaut JA, Mohty M, Chabannon C, Blaise D.

Hematol Oncol Stem Cell Ther. 2011;4(1):30-6.

2.

Family nutritional support improves survival, immune restoration and adherence in HIV patients receiving ART in developing country.

Serrano C, Laporte R, Ide M, Nouhou Y, de Truchis P, Rouveix E, Adamou A, Pauly V, Mattei JF, Gastaut JA.

Asia Pac J Clin Nutr. 2010;19(1):68-75.

3.

[Treating writer's cramp: 14 years' experience with botulinum toxin].

Somma-Mauvais H, Soulayrol S, Duvocelle A, Azulay JP, Gastaut JL.

Rev Neurol (Paris). 2010 Jun-Jul;166(6-7):630-8. doi: 10.1016/j.neurol.2009.12.008. Epub 2010 Feb 26. French.

PMID:
20189211
4.

A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose tolerance.

Poizot-Martin I, Drogoul-Vey MP, Di Stefano D, Jouve E, Fabre G, Saout A, Gastaut JA.

HIV Clin Trials. 2009 Jan-Feb;10(1):33-40. doi: 10.1310/hct1001-033.

PMID:
19362994
5.

Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.

Prebet T, Mozziconacci MJ, Sainty D, Arnoulet C, Lafage M, Dastugue N, Charbonnier A, Coso D, Gastaut JA, Blaise D, Vey N.

Leuk Lymphoma. 2009 Mar;50(3):485-7. doi: 10.1080/10428190802601148. No abstract available.

PMID:
19197723
6.

[Reversible post-transfusional encephalopathy].

Avram G, Girard N, Gastaut JL.

Rev Neurol (Paris). 2008 Mar;164 Spec No 1:F27-9. French. No abstract available.

PMID:
18680814
7.

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.

Cahu X, Mohty M, Faucher C, Chevalier P, Vey N, El-Cheikh J, Guillaume T, Furst S, Delaunay J, Ayari S, Moreau P, Gastaut JA, Harousseau JL, Blaise D.

Bone Marrow Transplant. 2008 Nov;42(10):689-91. doi: 10.1038/bmt.2008.231. Epub 2008 Aug 4. No abstract available.

PMID:
18679370
8.

Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma.

El-Cheikh J, Stoppa AM, Bouabdallah R, de Lavallade H, Coso D, de Collela JM, Auran-Schleinitz T, Gastaut JA, Blaise D, Mohty M.

Clin Lymphoma Myeloma. 2008 Jun;8(3):146-52. doi: 10.3816/CLM.2008.n.017.

PMID:
18650177
9.

Rank ligand stimulation induces a partial but functional maturation of human monocyte-derived dendritic cells.

Schiano de Colella JM, Barbarat B, Sweet R, Gastaut JA, Olive D, Costello RT.

Eur Cytokine Netw. 2008 Jun;19(2):81-8. doi: 10.1684/ecn.2008.0125. Epub 2008 Jun 1.

10.

Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.

de Lavallade H, Cassier PA, Bouabdallah R, El-Cheikh J, Faucher C, Fürst S, Coso D, Sainty D, Arnoulet C, Gastaut JA, Chetaille B, Xerri L, Blaise D, Mohty M.

Br J Haematol. 2008 Sep;142(5):848-50. doi: 10.1111/j.1365-2141.2008.07212.x. Epub 2008 Jul 9. No abstract available.

PMID:
18631344
11.

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison.

Mohty M, de Lavallade H, El-Cheikh J, Ladaique P, Faucher C, Fürst S, Vey N, Coso D, Stoppa AM, Gastaut JA, Chabannon C, Blaise D.

Leukemia. 2009 Jan;23(1):194-6. doi: 10.1038/leu.2008.164. Epub 2008 Jun 26. No abstract available.

PMID:
18580956
12.

Rituximab combined with chemotherapy for lymphoma during pregnancy.

Rey J, Coso D, Roger V, Bouayed N, Belmecheri N, Ivanov V, Gastaut JA, Bouabdallah R.

Leuk Res. 2009 Mar;33(3):e8-9. doi: 10.1016/j.leukres.2008.04.004. Epub 2008 May 19. No abstract available.

PMID:
18490055
13.

A case of rituximab-related urticarial reaction in cutaneous B-cell lymphoma.

Rey J, Wickenhauser S, Ivanov V, Coso D, Gastaut JA, Bouabdallah R.

J Eur Acad Dermatol Venereol. 2009 Feb;23(2):210. doi: 10.1111/j.1468-3083.2008.02792.x. Epub 2008 May 12. No abstract available.

PMID:
18482321
14.

[Chronic lymphocytic leukaemia: current management].

Aurran-Schleinitz T, Arnoulet C, Ivanov V, Coso D, Rey J, Schiano JM, Stoppa AM, Bouabdallah R, Gastaut JA.

Rev Med Interne. 2008 May;29(5):424-35. doi: 10.1016/j.revmed.2007.10.414. Epub 2007 Nov 20. Review. French.

PMID:
18359538
15.

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma.

de Lavallade H, El-Cheikh J, Faucher C, Fürst S, Stoppa AM, Coso D, Bouabdallah R, Chabannon C, Gastaut JA, Blaise D, Mohty M.

Bone Marrow Transplant. 2008 Jun;41(11):953-60. doi: 10.1038/bmt.2008.22. Epub 2008 Feb 25.

PMID:
18297115
16.

Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.

Valerio L, Yazdanpanah Y, Poizot-Martin I, Rosenthal E, Marimoutou C, Gastaut JA, Tran A, Dellamonica P, Freedberg KA, Pradier C.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):50-5.

17.

JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab.

Rey J, Belmecheri N, Bouayed N, Ivanov V, Coso D, Gastaut JA, Bouabdallah R.

Haematologica. 2007 Oct;92(10):e101. No abstract available.

18.

Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004.

Drogoul-Vey MP, Marimoutou C, Robaglia-Schlupp A, Beerli M, Gastaut JA, Cau P, Poizot-Martin I.

AIDS Care. 2007 Sep;19(8):1052-7.

PMID:
17852004
19.

Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes.

Etienne A, Carbuccia N, Adélaïde J, Bekhouche I, Rémy V, Sohn C, Sainty D, Gastaut JA, Olschwang S, Birnbaum D, Mozziconacci MJ, Chaffanet M.

Cancer Genet Cytogenet. 2007 Jul 1;176(1):80-8.

PMID:
17574970
20.

Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients.

Solas C, Simon N, Drogoul MP, Quaranta S, Frixon-Marin V, Bourgarel-Rey V, Brunet C, Gastaut JA, Durand A, Lacarelle B, Poizot-Martin I.

Br J Clin Pharmacol. 2007 Sep;64(3):353-62. Epub 2007 May 22.

21.

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.

Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D, Puig B, Gastaut JA, Maraninchi D, Vey N.

Cancer. 2007 Apr 1;109(7):1376-83.

22.

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation.

El-Cheikh J, Faucher C, Fürst S, Duran S, Berger P, Vey N, Stoppa AM, Bouabdallah R, Gastaut JA, Viens P, Blaise D, Mohty M.

Bone Marrow Transplant. 2007 Mar;39(5):301-6. Epub 2007 Jan 29.

PMID:
17262059
23.

Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma.

de Lavallade H, Mohty M, El-Cheikh J, Cassier PA, Faucher C, Fürst S, Vey N, Stoppa AM, Sainty D, Arnoulet C, Xerri L, Gastaut JA, Blaise D, Bouabdallah R.

Br J Haematol. 2006 Nov;135(3):408-10. Epub 2006 Sep 15. No abstract available.

PMID:
16978221
24.

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.

Coso D, Sebban C, Boulat O, Biron P, Rey J, Aurran T, Chabannon C, Xerri L, Chetaille B, Esterni B, Ivanov V, Stoppa AM, Schiano de Collela JM, Gastaut JA, Maraninchi D, Bouabdallah R.

Bone Marrow Transplant. 2006 Aug;38(3):217-22. Epub 2006 Jun 12.

PMID:
16770316
25.

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.

de Lavallade H, Faucher C, Fürst S, El-Cheikh J, Vey N, Coso D, Bouabdallah R, Stoppa AM, Gastaut JA, Blaise D, Mohty M.

Bone Marrow Transplant. 2006 Apr;37(7):709-10. No abstract available.

PMID:
16474410
26.

Familial autosomal dominant cortico-basal degeneration with the P301S mutation in the tau gene: an example of phenotype variability.

Casseron W, Azulay JP, Guedj E, Gastaut JL, Pouget J.

J Neurol. 2005 Dec;252(12):1546-8. No abstract available.

PMID:
16362832
27.

Nelfinavir in HIV-HCV coinfected patients: a 24-month follow-up in a cohort of 82 patients.

Poizot-Martin I, Marimoutou C, Drogoul-Vey MP, Vion-Dury F, Frixon-Marin V, Benhaim S, Poggi P, Gastaut JA.

AIDS Res Hum Retroviruses. 2005 Oct;21(10):841-4.

PMID:
16225410
28.

Discrepancy between blood and cerebral didanosine effects in HIV patients: a magnetic resonance spectroscopy study.

Poizot-Martin I, Milon MP, Enel P, Gastaut JA, Vion-Dury J.

Eur Neurol. 2005;53(4):223-5. Epub 2004 May 28. No abstract available.

PMID:
16015013
29.

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.

Mohty M, de Lavallade H, Ladaique P, Faucher C, Vey N, Coso D, Stoppa AM, Gastaut JA, Blaise D.

Leukemia. 2005 Jun;19(6):916-20.

PMID:
15843817
30.

One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.

Jourdan E, Rigal-Huguet F, Marit G, Vey N, Dastugue N, Fegueux N, Molina L, Gastaut JA, Legros L, Zerazhi H, Cailleres S, Bauduer F, Bordessoule D, Attal M, Blaise D, Pigneux A; BGMT Study Group.

Br J Haematol. 2005 May;129(3):403-10.

PMID:
15842665
31.

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B; MANIF 2000 Study Group.

Antivir Ther. 2005;10(1):53-61.

PMID:
15751763
32.

Single-agent thalidomide induces response in T-cell lymphoma.

Damaj G, Bouabdallah R, Vey N, Bilger K, Mohty M, Gastaut JA.

Eur J Haematol. 2005 Feb;74(2):169-71.

PMID:
15654910
33.

Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.

Colson P, Henry M, Tivoli N, Gallais H, Gastaut JA, Moreau J, Tamalet C.

J Med Virol. 2005 Mar;75(3):381-90.

PMID:
15648062
34.

Oxidative stress level in circulating neutrophils is linked to neurodegenerative diseases.

Vitte J, Michel BF, Bongrand P, Gastaut JL.

J Clin Immunol. 2004 Nov;24(6):683-92.

PMID:
15622453
35.

Phenotype variability in a caucasian family with dentatorubral-pallidoluysian atrophy.

Casseron W, Azulay JP, Broglin D, Kaphan E, Genton P, Le Ber I, Gastaut JL.

Eur Neurol. 2004;52(3):175-6. Epub 2004 Nov 2. No abstract available.

PMID:
15528920
36.

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation.

Mohty M, Blaise D, Faucher C, Bardou VJ, Gastaut JA, Viens P, Olive D, Gaugler B.

Leukemia. 2005 Jan;19(1):1-6.

PMID:
15526026
37.

Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center.

Damaj G, Mohty M, Vey N, Dincan E, Bouabdallah R, Faucher C, Stoppa AM, Gastaut JA.

Eur J Haematol. 2004 Dec;73(6):402-6. Review.

PMID:
15522061
38.

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation.

Mohty M, de Lavallade H, Faucher C, Bilger K, Vey N, Stoppa AM, Gravis G, Coso D, Viens P, Gastaut JA, Blaise D.

Bone Marrow Transplant. 2004 Sep;34(6):527-30.

PMID:
15286687
39.

The benefit of induction chemotherapy in patients age > or = 75 years.

Vey N, Coso D, Bardou VJ, Stoppa AM, Braud AC, Bouabdallah R, Sainty D, Mozziconacci MJ, Lafage M, Damaj G, Blaise D, Gastaut JA, Maraninchi D.

Cancer. 2004 Jul 15;101(2):325-31.

40.

Drug injection cessation among HIV-infected injecting drug users.

Bouhnik AD, Carrieri MP, Rey D, Spire B, Gastaut JA, Gallais H, Obadia Y; MANIF 2000 Study Group.

Addict Behav. 2004 Aug;29(6):1189-97.

PMID:
15236822
41.

Monoclonal antibodies and cytomegalovirus infections.

Damaj G, Charbonnier A, Bouabdallah R, Vey N, Coso D, Stoppa AM, Gastaut JA.

Eur J Haematol. 2004 Jul;73(1):73-4. No abstract available.

PMID:
15182343
42.

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation.

Mohty M, Boiron JM, Damaj G, Michallet AS, Bay JO, Faucher C, Perreau V, Bilger K, Coso D, Stoppa AM, Tabrizi R, Gastaut JA, Michallet M, Maraninchi D, Blaise D.

Bone Marrow Transplant. 2004 Jul;34(1):77-84.

PMID:
15133485
43.

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

Poizot-Martin I, Marimoutou C, Vion-Dury F, Grégoire R, Dinh T, Djemli K, Di Stefano D, Vague P, Gastaut JA.

HIV Clin Trials. 2004 Mar-Apr;5(2):86-90.

PMID:
15116284
44.

Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.

Rey D, Carrieri MP, Spire B, Loubière S, Dellamonica P, Gallais H, Cassuto GP, Gastaut JA, Obadia Y; MANIF 2000 Study Group.

J Urban Health. 2004 Mar;81(1):48-57.

45.

Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.

Costello RT, Zerazhi H, Charbonnier A, de Colella JM, Alzieu C, Poizot-Martin I, Cohen R, Bardou VJ, Xerri L, Olive D, Nezri M, Lepeu G, Gastaut JA.

Cancer. 2004 Feb 15;100(4):667-76.

46.

Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.

Mohty M, Mohty AM, Blaise D, Faucher C, Bilger K, Isnardon D, Sainty D, Gastaut JA, Viens P, Olive D, Gaugler B.

Bone Marrow Transplant. 2004 Apr;33(8):839-46.

PMID:
14767500
47.

Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.

Colson P, Henry M, Tourres C, Lozachmeur D, Gallais H, Gastaut JA, Moreau J, Tamalet C.

J Clin Microbiol. 2004 Feb;42(2):570-7.

48.

Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols.

Costello RT, Fauriat C, Rey J, Gastaut JA, Olive D.

Lancet Oncol. 2004 Jan;5(1):47-55. Review.

PMID:
14700608
49.

Natural killer cell-triggering receptors in patients with acute leukaemia.

Fauriat C, Marcenaro E, Sivori S, Rey J, Gastaut JA, Moretta A, Olive D, Costello RT.

Leuk Lymphoma. 2003 Oct;44(10):1683-9. Review.

PMID:
14692519
50.

Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.

Damaj G, Ivanov V, Le Brigand B, D'incan E, Doglio MF, Bilger K, Faucher C, Vey N, Gastaut JA.

Ann Hematol. 2004 Jun;83(6):390-3. Epub 2003 Dec 10.

PMID:
14666380

Supplemental Content

Loading ...
Support Center